Literature DB >> 21070771

Leishmania donovani: assessment of leishmanicidal effects of herbal extracts obtained from plants in the visceral leishmaniasis endemic area of Bihar, India.

Shubhankar K Singh1, Sanjiva Bimal, Shyam Narayan, Chandrawati Jee, Devla Bimal, P Das, Raageeva Bimal.   

Abstract

One obstacle faced in the effective control of visceral leishmaniasis (VL) is the limited number of available treatment options. Furthermore, control efforts have been hindered further by the emergence of Leishmania resistance to many of the available drugs. In this study, we investigated the anti-leishmanial properties of 30 medicinally important plants from the VL endemic area of Bihar, India and compared them to two available anti-leishmanial drugs (sodium antimony gluconate and amphotericin B) and two plant lectins (phytohemagglutinin and concanavalin A) on Leishmania donovani promastigotes in vitro at 24 and 48 h after initiation of culture. We identified eight plant extracts in addition to phytohemagglutinin and amphotericin B that significantly inhibited the growth of promastigotes (p < 0.03). We further studied the minimum effective concentrations as well as the effect on axenic amastigotes viability and the cell cytotoxicity on human peripheral blood of four (Agave americana, Azadirachta indica, Eclipta alba and Piper longum) of the eight plant extracts that induced significant promastigotes killing (p = 0.00098). Effect-based dose finding analysis revealed that the threshold concentration of A. americana required to eliminate L. donovani after 24h was 0.05 mg/ml. A. indica and P. longum plant extracts eliminated L. donovani promastigotes after 48 h at concentrations of 0.1 and 0.5mg/ml, respectively. E. alba eliminated the promastigotes at a concentration of 0.5mg/ml within 24h. The axenic amastigote killing response was 1.90-, 2.52- and 1.3-fold higher than the promastigote killing response with A. indica, A. americana and E. alba plant extracts, respectively. A. americana and A. indica, respectively, led to approximate 2.5- and 1.3-fold declines in mitochondrial dehydrogenase activity compared with control. E. alba stimulation resulted in an up-regulation of dehydrogenase activity (p = 0.00329). The CSA from P. longum was found to be least cytotoxic; the observed difference in mitochondrial activity was insignificant (p = 0.16314). Further studies may reveal the pharmacological significance of many of the plants with anti-leishmanial properties identified in the present study.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21070771     DOI: 10.1016/j.exppara.2010.10.014

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  11 in total

Review 1.  Antileishmanial and Immunomodulatory Activity of Allium sativum (Garlic): A Review.

Authors:  Masoud Foroutan-Rad; Khosrow Hazrati Tappeh; Shahram Khademvatan
Journal:  J Evid Based Complementary Altern Med       Date:  2015-12-30

2.  Leishmania donovani pteridine reductase 1: comparative protein modeling and protein-ligand interaction studies of the leishmanicidal constituents isolated from the fruits of Piper longum.

Authors:  Shakti Sahi; Parul Tewatia; Sabari Ghosal
Journal:  J Mol Model       Date:  2012-07-03       Impact factor: 1.810

Review 3.  Betelvine (Piper betle L.): A comprehensive insight into its ethnopharmacology, phytochemistry, and pharmacological, biomedical and therapeutic attributes.

Authors:  Protha Biswas; Uttpal Anand; Suchismita Chatterjee Saha; Nishi Kant; Tulika Mishra; Harison Masih; Ananya Bar; Devendra Kumar Pandey; Niraj Kumar Jha; Madhumita Majumder; Neela Das; Vijaykumar Shivaji Gadekar; Mahipal S Shekhawat; Manoj Kumar; Jarosław Proćków; José M Pérez de la Lastra; Abhijit Dey
Journal:  J Cell Mol Med       Date:  2022-05-02       Impact factor: 5.295

4.  Potential of the natural products against leishmaniasis in Old World - a review of in-vitro studies.

Authors:  Sofia Cortes; Carolina Bruno de Sousa; Thiago Morais; João Lago; Lenea Campino
Journal:  Pathog Glob Health       Date:  2020-04-27       Impact factor: 2.894

5.  Evaluation of Antileishmanial Activity of Albaha Medicinal Plants against Leishmania amazonensis.

Authors:  Saeed S Al-Sokari; Nasser A Awadh Ali; Lianet Monzote; Mohamed A Al-Fatimi
Journal:  Biomed Res Int       Date:  2015-08-19       Impact factor: 3.411

6.  Apoptosis mediated leishmanicidal activity of Azadirachta indica bioactive fractions is accompanied by Th1 immunostimulatory potential and therapeutic cure in vivo.

Authors:  Garima Chouhan; Mohammad Islamuddin; Muzamil Y Want; Malik Z Abdin; Hani A Ozbak; Hassan A Hemeg; Dinkar Sahal; Farhat Afrin
Journal:  Parasit Vectors       Date:  2015-03-26       Impact factor: 3.876

7.  Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis.

Authors:  Fauzia Jamal; Pushkar Shivam; Sarita Kumari; Manish Kumar Singh; Abul Hasan Sardar; Selvasankar Murugesan; Shyam Narayan; Anil Kumar Gupta; Krishna Pandey; V N R Das; Vahab Ali; Sanjiva Bimal; Pradeep Das; Shubhankar K Singh
Journal:  PLoS One       Date:  2017-08-18       Impact factor: 3.240

Review 8.  Antiparasitic activity in Asteraceae with special attention to ethnobotanical use by the tribes of Odisha, India.

Authors:  Sujogya Kumar Panda; Walter Luyten
Journal:  Parasite       Date:  2018-03-12       Impact factor: 3.000

9.  Cedrus deodara: In vitro antileishmanial efficacy & immumomodulatory activity.

Authors:  Shyam Narayan; Chandreshwar Prasad Thakur; Shiv Bahadur; Meenakshi Thakur; Shashi Nath Pandey; Ajit Kumar Thakur; Dipendra K Mitra; Pulok K Mukherjee
Journal:  Indian J Med Res       Date:  2017-12       Impact factor: 2.375

Review 10.  Hunting Bioactive Molecules from the Agave Genus: An Update on Extraction and Biological Potential.

Authors:  Misael Bermúdez-Bazán; Gustavo Adolfo Castillo-Herrera; Judith Esmeralda Urias-Silvas; Antonio Escobedo-Reyes; Mirna Estarrón-Espinosa
Journal:  Molecules       Date:  2021-11-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.